Lantern Pharma (LTRN) Institutional Ownership $4.08 +0.02 (+0.49%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$4.06 -0.02 (-0.49%) As of 08/29/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lantern Pharma (NASDAQ:LTRN)CurrentInstitutional OwnershipPercentage28.62%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$4.32MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$868.76K Get LTRN Insider Trade Alerts Want to know when executives and insiders are buying or selling Lantern Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data LTRN Institutional Buying and Selling by Quarter Lantern Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2025 NewEdge Advisors LLC56,507$179K0.0%-5.7%0.524% 8/12/2025 XTX Topco Ltd12,624$40K0.0%N/A0.117% 8/12/2025 BIOS Capital Management LP1,075,952$3.40M4.7%-10.9%9.981% 8/5/2025 Westside Investment Management Inc.35,900$113K0.0%+17.1%0.333% 5/16/2025 NewEdge Advisors LLC59,924$212K0.0%-12.3%0.556% 4/23/2025 Perigon Wealth Management LLC39,387$139K0.0%+169.8%0.365% 2/17/2025 Two Sigma Investments LP16,545$53K0.0%-51.8%0.153% 2/14/2025 Voss Capital LP50,000$160K0.0%N/A0.464% 2/13/2025 NewEdge Advisors LLC68,359$218K0.0%-50.2%0.634% 2/13/2025 Renaissance Technologies LLC87,300$278K0.0%+3.9%0.810% Get the Latest News and Ratings for LTRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lantern Pharma and its competitors with MarketBeat's FREE daily newsletter. 2/10/2025 BIOS Capital Management LP1,207,709$3.85M4.1%N/A11.203% 2/7/2025 CM Management LLC200,000$638K0.6%+8.1%1.855% 1/31/2025Sanctuary Advisors LLC10,000$32K0.0%N/A0.093% 1/24/2025 DAVENPORT & Co LLC25,814$82K0.0%-52.0%0.239% 1/22/2025 Perigon Wealth Management LLC14,600$47K0.0%-49.5%0.135% 11/20/2024 Westside Investment Management Inc.30,650$112K0.0%+166.5%0.284% 8/9/2024 Renaissance Technologies LLC81,800$382K0.0%+24.5%0.760% 8/9/2024 Dimensional Fund Advisors LP18,413$86K0.0%+55.7%0.171% 8/2/2024 CM Management LLC80,000$374K0.3%+23.1%0.743% 7/17/2024 Westside Investment Management Inc.11,500$54K0.0%N/A0.107% 5/14/2024 CM Management LLC65,000$572K0.5%-18.8%0.604% 5/10/2024 Tocqueville Asset Management L.P.19,000$167K0.0%N/A0.177% 4/10/2024 Pathway Financial Advisors LLC25,001$220K0.1%-12.3%0.233% 2/12/2024 Redmond Asset Management LLC40,662$174K0.1%-12.6%0.374% 2/8/2024 Meridian Wealth Management LLC19,660$84K0.0%+18.0%0.181% 2/1/2024 Sigma Planning Corp11,875$51K0.0%-34.5%0.109% 2/1/2024 Pathway Financial Advisors LLC28,501$122K0.0%-13.0%0.262% 10/30/2023 Pathway Financial Advisors LLC32,771$112K0.0%+134.1%0.302% 10/17/2023 Meridian Wealth Management LLC16,660$57K0.0%N/A0.153% 8/10/2023 Carlson Capital L P95,000$536K0.0%-23.9%0.875% 8/4/2023 CM Management LLC75,000$423K0.4%+25.0%0.691% 7/19/2023 Pathway Financial Advisors LLC14,001$79K0.0%N/A0.129% 2/9/2023 CM Management LLC60,000$362K0.4%+20.0%0.552% 2/9/2023 Wolff Wiese Magana LLC27,098$164K0.1%-11.0%0.250% 2/7/2023Lynwood Capital Management Inc.12,000$73K0.1%N/A0.110% 11/15/2022 Carlson Capital L P168,000$803K0.1%-1.2%1.547% 11/4/2022 CM Management LLC50,000$239K0.3%+10.9%0.462% 8/8/2022 CM Management LLC45,100$258K0.3%+33.6%0.416% 7/15/2022 Wolff Wiese Magana LLC31,575$180K0.1%-12.7%0.292% 7/11/2022 Sanders Morris Harris LLC366,030$2.06M0.5%-4.7%3.379% Forget Tesla — This Tiny AI Stock Is Musk’s Real Play (Ad)While Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it could transform warfare, robotics, and the global economy. But you don’t need to buy Tesla or wait for xAI to IPO to benefit. One overlooked public company is supplying the critical tech behind Musk’s AI push — and it trades for a fraction of Nvidia’s price. Hedge funds are already loading up, but most investors haven’t noticed yet.See the full details on this “backdoor” Musk bet here5/9/2022 CM Management LLC33,765$241K0.2%N/A0.312% 5/9/2022 Wolff Wiese Magana LLC36,155$259K0.2%+5.9%0.334% 4/11/2022 Sanders Morris Harris LLC384,228$2.75M0.5%+14.2%3.564% 2/4/2022 Envestnet Asset Management Inc.10,542$84K0.0%N/A0.094% 2/4/2022 Redmond Asset Management LLC49,187$393K0.1%+3.7%0.440% 2/3/2022 Advisor Group Holdings Inc.5,331$43K0.0%+92.5%0.048% 2/2/2022 Sanders Morris Harris LLC336,425$2.57M0.4%N/A3.007% 2/2/2022 Sigma Planning Corp17,600$140K0.0%N/A0.157% 1/14/2022 Spire Wealth Management4,050$32K0.0%+285.7%0.036% 11/9/2021BlackRock Inc.23,074$258K0.0%-8.1%0.206% 11/5/2021 Advisor Group Holdings Inc.2,770$31K0.0%+177.0%0.025% 11/2/2021Raymond James & Associates25,879$289K0.0%N/A0.231% 10/29/2021 GWM Advisors LLC155,859$1.74M0.0%+3.0%1.394% 10/22/2021 Redmond Asset Management LLC47,442$530K0.2%+4.3%0.424% 10/15/2021 Wolff Wiese Magana LLC35,316$395K0.3%+24.7%0.316% 8/16/2021Corriente Advisors LLC656,364$9.58M5.2%-8.0%5.869% 8/13/2021 Geode Capital Management LLC55,479$809K0.0%+21.1%0.496% 8/13/2021 Vanguard Group Inc.269,429$3.93M0.0%+4.0%2.409% 8/11/2021 Bank of New York Mellon Corp26,765$391K0.0%+127.3%0.239% 5/18/2021 Morgan Stanley50,702$920K0.0%+81.6%0.453% (Data available from 1/1/2016 forward) LTRN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LTRN shares? During the previous two years, 17 institutional investors and hedge funds held shares of Lantern Pharma. The most heavily invested institutionals were BIOS Capital Management LP ($3.40M), CM Management LLC ($638K), Renaissance Technologies LLC ($278K), Pathway Financial Advisors LLC ($220K), NewEdge Advisors LLC ($179K), Redmond Asset Management LLC ($174K), and Tocqueville Asset Management L.P. ($167K).Learn more on Lantern Pharma's institutional investors. What percentage of Lantern Pharma's stock is owned by institutional investors? 28.62% of Lantern Pharma's stock is owned by institutional investors. Learn more on LTRN's institutional investor holdings. Which institutional investors have been buying Lantern Pharma's stock? Of the 12 institutional investors that purchased Lantern Pharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BIOS Capital Management LP ($1.21M), Voss Capital LP ($50K), Westside Investment Management Inc. ($35.90K), CM Management LLC ($30K), Perigon Wealth Management LLC ($24.79K), Meridian Wealth Management LLC ($19.66K), and Renaissance Technologies LLC ($19.40K). How much institutional buying is happening at Lantern Pharma? Institutional investors have bought a total of 1,347,820 shares in the last 24 months. This purchase volume represents approximately $4.32M in transactions. Which of Lantern Pharma's major shareholders have been selling company stock? The following institutional investors have sold Lantern Pharma stock in the last 24 months: BIOS Capital Management LP ($131.76K), NewEdge Advisors LLC ($80.83K), DAVENPORT & Co LLC ($28K), Two Sigma Investments LP ($17.80K), and Perigon Wealth Management LLC ($14.30K). How much institutional selling is happening at Lantern Pharma? Institutional investors have sold a total of 272,683 shares in the last 24 months. This volume of shares sold represents approximately $868.76K in transactions. Related Companies MDWD Major Shareholders VYGR Major Shareholders EPRX Major Shareholders ENTA Major Shareholders KRRO Major Shareholders RAPT Major Shareholders TNYA Major Shareholders TIL Major Shareholders DERM Major Shareholders CCCC Major Shareholders This page (NASDAQ:LTRN) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lantern Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lantern Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LTRN Stock Alerts